Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2
List of Figures 9
2 Introduction 11
2.1 What Is This Report About?
11
3 Definitions of Markets Covered in the Report 12
3.1 Diabetes Care
Devices 12
3.2 Glucose Monitoring Devices 12
3.2.1 Blood Glucose
Meters 12
3.2.2 Blood Glucose Strips 12
3.3 Insulin Delivery 12
3.3.1 Insulin Pens 12
3.3.2 Insulin Syringes 13
3.3.3 Insulin Pumps
13
3.3.4 Traditional Insulin Pump Accessories 13
4 Healthcare Sector
Review 14
4.1 Healthcare Expenditure 14
4.2 Healthcare Infrastructure
15
4.3 Healthcare Policy 17
4.4 United Kingdom Healthcare Trade
Statistics 18
5 Regulation System 19
5.1 Medical Equipment Approval
Process 19
5.1.1 Classification of Medical Devices 19
5.1.2 Conformity
Assessment Process 27
5.2 Medical Device approval fee 31
5.3 Post
Market Surveillance (PMS) 32
6 Pricing and Reimbursement 33
6.1 Market
Pricing 33
6.2 Government Policies for Reimbursement 33
7 Distribution
Structure 35
8 Diabetes Care Devices In United Kingdom 36
8.1 Diabetes
Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 36
8.2
Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
37
8.3 Diabetes Care Devices, United Kingdom, Category Volume (Units),
2000-2015 41
8.4 Diabetes Care Devices, United Kingdom, Company Share
(2007-2008) 44
9 Glucose Monitoring In United Kingdom 45
9.1 Glucose
Monitoring Overall Revenue (2000-2015) 45
9.1.1 Blood Glucose Meters
Overall Revenue (2000-2015) 46
9.2 Glucose Monitoring Overall Volume
(2000-2015) 48
9.2.1 Blood Glucose Meters Overall Volume (2000-2015)
49
9.3 Glucose Monitoring Average Price (2000-2015) 51
9.4 Glucose
Monitoring Distribution Share (2007-2008) 52
9.5 Glucose Monitoring,
United Kingdom, Company Share (2007-2008) 53
10 Insulin Delivery In United
Kingdom 54
10.1 Insulin Delivery Overall Revenue (2000-2015) 54
10.1.1
Insulin Pens Overall Revenue (2000-2015) 56
10.2 Insulin Delivery Overall
Volume (2000-2015) 58
10.2.1 Insulin Pens Overall Volume (2000-2015)
59
10.3 Insulin Delivery Average Price (2000-2015) 61
10.4 Insulin
Delivery Distribution Share (2007-2008) 62
10.5 Insulin Delivery, United
Kingdom, Company Share (2007-2008) 63
11 Overview of Key Companies in
United Kingdom Diabetes Care Devices Market 64
11.1 F. Hoffmann-La Roche
Ltd. 64
11.1.1 Company Overview 64
11.1.2 Value Chain Analysis 65
11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 67
11.2 LifeScan, Inc.
68
11.2.1 Company Overview 68
11.2.2 LifeScan, Inc. Pipeline Products
68
11.3 Bayer HealthCare AG 70
11.3.1 Company Overview 70
11.3.2
Value Chain Analysis 71
11.3.3 Bayer HealthCare AG Pipeline Products
73
11.4 Abbott Laboratories 74
11.4.1 Company Overview 74
11.4.2
Value Chain Analysis 75
11.4.3 Abbott Laboratories Pipeline Products
77
11.5 Novo Nordisk A/S 79
11.5.1 Company Overview 79
11.5.2 Novo
Nordisk A/S Pipeline Products 79
11.6 Becton, Dickinson and Company 81
11.6.1 Company Overview 81
11.6.2 Value Chain Analysis 81
11.7 Eli
Lilly and Company 83
11.7.1 Company Overview 83
11.7.2 Value Chain
Analysis 83
11.7.3 Eli Lilly and Company Pipeline Products 86
11.8
Medtronic, Inc. 87
11.8.1 Company Overview 87
11.8.2 Value Chain
Analysis 88
11.8.3 Medtronic, Inc. Pipeline Products 90
11.9 ARKRAY,
Inc. 98
11.9.1 Company Overview 98
11.9.2 ARKRAY, Inc. Pipeline
Products 98
11.10 Terumo Corporation 100
11.10.1 Company Overview
100
11.10.2 Value Chain Analysis 100
11.11 Animas Corporation 103
11.11.1 Company Overview 103
11.12 Sanofi-Aventis 103
11.12.1 Company
Overview 103
11.13 Smiths Medical 104
11.13.1 Company Overview 104
11.13.2 Value Chain Analysis 105
12 Recent Developments 107
12.1
Strategy And Business Planning 107
12.1.1 Mar 25, 2009: Smiths Medical
Intents To Stop Selling Deltec Cozmo Insulin Pumps 107
12.2 Government and
Public Interest 108
12.2.1 Apr 29, 2009: Warning About Failing Insulin
Infusion Pump, UK 108
12.3 Product News 108
12.3.1 Mar 19, 2009:
Accu-Chek Inform II Blood Glucose Monitoring System Helps To Improve Patient
Care 108
12.3.2 Feb 03, 2009: Accu-Chek Aviva Nano Designed To Motivate
Patients For Self-Management Of Diabetes 109
13 Appendix 110
13.1
Global Markets Direct Research Methodology 110
13.2 Coverage 111
13.3
Secondary Research 111
13.4 Primary Research 112
13.5 Models 112
13.6 Forecasts 113
13.7 Expert Panel Validation 113
13.8 Currency
Conversion 114
13.9 Contact Us 115
13.10 Disclaimer 115
1.1 List of Tables
Table 1: Number of Doctor by Specialty in UK, 2003
- 2007 16
Table 2: United Kingdom Healthcare Trade Statistics, 2001-2006
18
Table 3: Medical Device Approval Fee in UK, 2006 32
Table 4:
Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
36
Table 5: Diabetes Care Devices, United Kingdom, Overall Revenue ($
mn), 2000-2015 37
Table 6: Diabetes Care Devices, United Kingdom,
Cross-Category Analysis, 2000-2015 38
Table 7: Diabetes Care Devices,
United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008 39
Table 8:
Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Forecast,
2008-2015 40
Table 9: Diabetes Care Devices, United Kingdom, Category
Volume (Units), 2000-2015 41
Table 10: Diabetes Care Devices, United
Kingdom, Category Volume (Units), Historic, 2000-2008 42
Table 11:
Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast,
2008-2015 43
Table 12: Diabetes Care Devices, United Kingdom, Company
Share by Revenue ($ mn), 2007-2008 44
Table 13: Glucose Monitoring,
United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 45
Table
14: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment,
Forecast, 2008-2015 45
Table 15: Blood Glucose Meters, United
Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 46
Table 16:
Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 47
Table 17: Glucose Monitoring, United Kingdom,
Volume (Units) by Segment, Historic, 2000-2008 48
Table 18: Glucose
Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
48
Table 19: Blood Glucose Meters, United Kingdom, Volume (Units) by
Sub-Segment, Historic, 2000-2008 49
Table 20: Blood Glucose Meters,
United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015 50
Table 21: Glucose Monitoring, United Kingdom, Average Price ($),
Historic, 2000-2008 51
Table 22: Glucose Monitoring, United Kingdom,
Average Price ($), Forecast, 2008-2015 51
Table 23: Glucose
Monitoring, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
52
Table 24: Glucose Monitoring, United Kingdom, Company Share by
Revenue ($ mn), 2007-2008 53
Table 25: Insulin Delivery, United
Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 54
Table 26:
Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Forecast,
2008-2015 55
Table 27: Insulin Pens, United Kingdom, Revenue ($ mn)
by Sub-Segment, Historic, 2000-2008 56
Table 28: Insulin Pens, United
Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 57
Table 29:
Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic,
2000-2008 58
Table 30: Insulin Delivery, United Kingdom, Volume
(Units) by Segment, Forecast, 2008-2015 58
Table 31: Insulin Pens,
United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008 59
Table 32: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 60
Table 33: Insulin Delivery, United Kingdom,
Average Price ($), Historic, 2000-2008 61
Table 34: Insulin Delivery,
United Kingdom, Average Price ($), Forecast, 2008-2015 61
Table 35:
Insulin Delivery, United Kingdom, Distribution Share by Revenue ($mn),
2007-2008 62
Table 36: Insulin Delivery, United Kingdom, Company
Share by Revenue ($ mn), 2007-2008 63
Table 37: F. Hoffmann-La Roche
Ltd Pipeline Products by Equipment Type 67
Table 38: F. Hoffmann-La
Roche Ltd Pipeline Products by Development Stage 67
Table 39: F.
Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 67
Table 40:
LifeScan, Inc. Pipeline Products by Equipment Type 68
Table 41:
LifeScan, Inc. Pipeline Products by Development Stage 68
Table 42:
LifeScan, Inc. Pipeline Products by Therapy Area 68
Table 43:
LifeScan, Inc. Pipeline Products by Clinical Trials 69
Table 44:
LifeScan, Inc. Pipeline Products by News Summary 69
Table 45: Bayer
HealthCare AG Pipeline Products by Equipment Type 73
Table 46: Bayer
HealthCare AG Pipeline Products by Development Stage 73
Table 47:
Bayer HealthCare AG Pipeline Products by Therapy Area 73
Table 48:
Bayer HealthCare AG Pipeline Products by News Summary 73
Table 49:
Abbott Laboratories Pipeline Products by Equipment Type 77
Table 50:
Abbott Laboratories Pipeline Products by Development Stage 77
Table 51:
Abbott Laboratories Pipeline Products by Therapy Area 77
Table 52:
Abbott Laboratories Pipeline Products by Clinical Trials 78
Table 53:
Abbott Laboratories Pipeline Products by News Summary 78
Table 54:
Novo Nordisk A/S Pipeline Products by Equipment Type 79
Table 55:
Novo Nordisk A/S Pipeline Products By Development Stage 79
Table 56:
Novo Nordisk A/S Pipeline Products By Therapy Area 80
Table 57: Novo
Nordisk A/S Pipeline Products By Clinical Trials 80
Table 58: Eli
Lilly and Company Pipeline Products by Equipment Type 86
Table 59:
Eli Lilly and Company Pipeline Products by Development Stage 86
Table 60:
Eli Lilly and Company Pipeline Products by Therapy Area 86
Table 61:
Eli Lilly and Company Pipeline Products by Clinical Trials 86
Table 62:
Eli Lilly and Company Pipeline Products by News Summary 86
Table 63:
Medtronic, Inc. Pipeline Products by Equipment Type 90
Table 64:
Medtronic, Inc. Pipeline Products By Development Stage 92
Table 65:
Medtronic, Inc. Pipeline Products By Therapy Area 94
Table 66:
Medtronic, Inc. Pipeline Products By Clinical Trials 96
Table 67:
Medtronic, Inc. Pipeline Products By News Summary 97
Table 68:
ARKRAY, Inc. Pipeline Products by Equipment Type 98
Table 69: ARKRAY,
Inc. Pipeline Products by Development Stage 98
Table 70: ARKRAY, Inc.
Pipeline Products by Clinical Trials 99
Table 71: ARKRAY, Inc.
Pipeline Products by News Summary 99
Table 72: USD to Local Currency,
Average Exchange Rate 2008 114
1.2 List of Figures
Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006 15
Figure 2:
Flowchart for Classification of Non-invasive Devices in UK, 2007 20
Figure
3: Flowchart for Classification of Invasive Devices in UK, 2007 21
Figure
4: Flowchart for Classification of Invasive Devices in UK, 2007 22
Figure
5: Flowchart for Classification of Invasive Devices in UK, 2007 23
Figure
6: Flowchart for Classification of Invasive Devices in UK, 2007 24
Figure
7: Flowchart for Classification of Active Devices in UK, 2007 25
Figure 8:
Flowchart for Classification of Active Devices in UK, 2007 26
Figure 9:
Flowchart for Classification of Devices except Non-invasive, Invasive and
Active Devices in UK, 2007 27
Figure 10: Conformity Assessment of Class-I
Medical Devices in UK, 2007 28
Figure 11: Conformity Assessment of
Class-IIa Medical Devices in UK, 2007 29
Figure 12: Conformity Assessment
of Class-IIb Medical Devices in UK, 2007 30
Figure 13: Conformity
Assessment of Class-III Medical Devices in UK, 2007 31
Figure 14:
Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
36
Figure 15: Diabetes Care Devices, United Kingdom, Overall Revenue
($ mn), 2000-2015 37
Figure 16: Diabetes Care Devices, United
Kingdom, Cross-Category Analysis, 2000-2015 38
Figure 17: Diabetes
Care Devices, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
39
Figure 18: Diabetes Care Devices, United Kingdom, Overall Revenue
($ mn), Forecast, 2008-2015 40
Figure 19: Diabetes Care Devices,
United Kingdom, Category Volume (Units), 2000-2015 41
Figure 20:
Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic,
2000-2008 42
Figure 21: Diabetes Care Devices, United Kingdom,
Category Volume (Units), Forecast, 2008-2015 43
Figure 22: Diabetes
Care Devices, United Kingdom, Company Share (%), 2008 44
Figure 23:
Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 46
Figure 24: Blood Glucose Meters, United Kingdom, Revenue
($ mn) by Sub-Segment, Forecast, 2008-2015 47
Figure 25: Blood
Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic,
2000-2008 49
Figure 26: Blood Glucose Meters, United Kingdom, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 50
Figure 27: Glucose
Monitoring, United Kingdom, Company Share (%), 2008 53
Figure 28:
Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Historic,
2000-2008 54
Figure 29: Insulin Delivery, United Kingdom, Revenue ($
mn) by Segment, Forecast, 2008-2015 55
Figure 30: Insulin Pens,
United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 56
Figure 31: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 57
Figure 32: Insulin Pens, United Kingdom,
Volume (Units) by Sub-Segment, Historic, 2000-2008 59
Figure 33:
Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast,
2008-2015 60
Figure 34: Insulin Delivery, United Kingdom, Company
Share (%), 2008 63
Figure 35: F. Hoffmann-La Roche Ltd Value Chain
Analysis 65
Figure 36: Bayer HealthCare AG Value Chain Analysis
71
Figure 37: Abbott Laboratories Value Chain Analysis 75
Figure
38: Becton, Dickinson and Company Value Chain Analysis 81
Figure 39:
Eli Lilly and Company Value Chain Analysis 83
Figure 40:
Medtronic, Inc. Value Chain Analysis 88
Figure 41: Terumo Corporation
Value Chain Analysis 100
Figure 42: Smiths Medical Value Chain
Analysis 105
Figure 43: Global Markets Direct Methodology 110
|
Related Report
|
View Cart
